Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Chugh, Pauline E ^a   Sin, Sang Hoon ^a   Ozgur, Sezgin ^a   Henry, David H ^b   Menezes, Prema ^c   Griffith, Jack ^a   Eron, Joseph J ^c   Damania, Blossom ^a   Dittmer, Dirk P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD9 ANTIGEN; FLOTILLIN 2; HEAT SHOCK PROTEIN 90; INTERLEUKIN 6; MICRORNA; MICRORNA 106A; MICRORNA 106B; MICRORNA 150; MICRORNA 16; MICRORNA 17 92; MICRORNA 195; MICRORNA 197; MICRORNA 19A; MICRORNA 205; MICRORNA 21; MICRORNA 23A; MICRORNA 27A; MICRORNA 30C; MICRORNA 425 5P; MICRORNA 451; MICRORNA 454; MICRORNA 548A; MICRORNA 601; MICRORNA 625; MICRORNA 886 5P; MICRORNA 92A; RIBONUCLEASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; GENETIC ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ULTRACENTRIFUGATION; VIRUS LOAD; VIRUS PATHOGENESIS; WESTERN BLOTTING;

EID: 84884765359     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003484     Document Type: Article

References (114)

1. Cho WC, (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
2. Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, et al. (2011) The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol 85: 9801-9810.
3. O'Hara AJ, Vahrson W, Dittmer DP, (2008) Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. Blood 111: 2347-2353.
4. O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, et al. (2009) Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood 113: 5938-5941.
5. Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, et al. (2011) Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 117: 3140-3146.
6. O'Hara AJ, Chugh P, Wang L, Netto EM, Luz E, et al. (2009) Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog 5: e1000389.
7. Abend JR, Uldrick T, Ziegelbauer JM, (2010) Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 84: 12139-12151.
8. Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, et al. (2010) KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev 24: 195-205.
9. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
10. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718.
11. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, et al. (2011) Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res 71: 550-560.
12. Marshall V, Parks T, Bagni R, Wang CD, Samols MA, et al. (2007) Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis 195: 645-659.
13. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
14. Haecker I, Gay LA, Yang Y, Hu J, Morse AM, et al. (2012) Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8: e1002884.
15. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, et al. (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3: e65.
16. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, et al. (2010) Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog 6: e1000742.
17. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10: 515-526.
18. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, et al. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83: 3333-3341.
19. Boss IW, Plaisance KB, Renne R, (2009) Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol 17: 544-553.
20. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
21. Ziegelbauer JM, Sullivan CS, Ganem D, (2009) Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41: 130-134.
22. Lu CC, Li Z, Chu CY, Feng J, Sun R, et al. (2010) MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep 11: 784-790.
23. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM, (2010) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 84: 2697-2706.
24. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
25. Krown SE, (2011) Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities. Curr Opin Oncol 23: 463-468.
26. Krown SE, Lee JY, Dittmer DP, (2008) More on HIV-associated Kaposi's sarcoma. N Engl J Med 358: 535-536 author reply 536.
27. Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, et al. (2010) Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer 127: 2395-2401.
28. Bellare P, Ganem D, (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570-575.
29. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, et al. (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102: 5570-5575.
30. Fan AC, Goldrick MM, Ho J, Liang Y, Bachireddy P, et al. (2008) A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice. Mol Cancer 7: 74.
31. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
32. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
33. Kroh EM, Parkin RK, Mitchell PS, Tewari M, (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
34. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
35. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.
36. Turchinovich A, Weiz L, Langheinz A, Burwinkel B, (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-7233.
37. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, et al. (2011) Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 33: 455-467.
38. Meckes DG Jr, Raab-Traub N, (2011) Microvesicles and viral infection. J Virol 85: 12844-12854.
39. Thery C, Zitvogel L, Amigorena S, (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579.
40. Cho JA, Yeo DJ, Son HY, Kim HW, Jung DS, et al. (2005) Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer 114: 613-622.
41. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, et al. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7: 297-303.
42. Yang C, Kim SH, Bianco NR, Robbins PD, (2011) Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One 6: e22517.
43. Yang C, Robbins PD, (2011) The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011: 842849.
44. Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, et al. (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 107: 20370-20375.
45. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, et al. (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107: 6328-6333.
46. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558-570.
47. Staudt MR, Kanan Y, Jeong JH, Papin JF, Hines-Boykin R, et al. (2004) The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res 64: 4790-4799.
48. An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, et al. (2006) Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 80: 4833-4846.
49. Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD, et al. (2007) Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 109: 2165-2173.
50. Sin SH, Dittmer DP, (2013) Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. Blood 121: 2952-2963.
51. Chang HH, Ganem D, (2013) A Unique Herpesviral Transcriptional Program in KSHV-Infected Lymphatic Endothelial Cells Leads to mTORC1 Activation and Rapamycin Sensitivity. Cell Host Microbe 13: 429-440.
52. Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, et al. (2007) In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11: 245-258.
53. Jones T, Ye F, Bedolla R, Huang Y, Meng J, et al. (2012) Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J Clin Invest 122: 1076-1081.
54. Chugh P, Tamburro K, Dittmer DP, (2010) Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays. J Vis Exp.
55. Chugh P, Dittmer DP, (2012) Potential pitfalls in microRNA profiling. Wiley Interdiscip Rev RNA 3: 601-616.
56. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH, (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32: 2747-2755.
57. Mathivanan S, Simpson RJ, (2009) ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9: 4997-5000.
58. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ, (2012) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40: D1241-1244.
59. Langhorst MF, Reuter A, Stuermer CA, (2005) Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci 62: 2228-2240.
60. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, et al. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319: 1244-1247.
61. Myoung J, Ganem D, (2011) Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J Virol 85: 9767-9777.
62. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D, (1998) Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72: 5182-5188.
63. Sakurada S, Katano H, Sata T, Ohkuni H, Watanabe T, et al. (2001) Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission. J Virol 75: 7717-7722.
64. Lin X, Li X, Liang D, Lan K, (2012) MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions. J Virol 86: 12717-12730.
65. Lechowicz MJ, Lin L, Ambinder RF, (2002) Epstein-Barr virus DNA in body fluids. Curr Opin Oncol 14: 533-537.
66. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM, (2000) Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 111: 239-246.
67. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM, (2001) Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies. Ann N Y Acad Sci 945: 80-83.
68. Lit LC, Chan KC, Leung SF, Lei KI, Chan LY, et al. (2004) Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. Clin Chem 50: 1842-1845.
69. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
70. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, et al. (2010) Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
71. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, et al. (2012) The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 31: 5162-5171.
72. Tamburro KM, Yang D, Poisson J, Fedoriw Y, Roy D, et al. (2012) Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A. Virology 433: 220-225.
73. Bhatt AP, Bhende PM, Sin SH, Roy D, Dittmer DP, et al. (2010) Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood 115: 4455-4463.
74. Roy D, Dittmer DP, (2011) Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma. Am J Pathol 179: 2108-2119.
75. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B, (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66: 3658-3666.
76. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ, (2008) Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371: 139-154.
77. Liu Y, Sun R, Lin X, Liang D, Deng Q, et al. (2012) Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J Virol 86: 1372-1381.
78. Fujimuro M, Hayward SD, (2003) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77: 8019-8030.
79. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, et al. (2009) Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A 106: 11725-11730.
80. West J, Damania B, (2008) Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 82: 5440-5449.
81. Mansouri M, Rose PP, Moses AV, Fruh K, (2008) Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol 82: 9615-9628.
82. Li L, Shi JY, Zhu GQ, Shi B, (2012) MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell Biochem 113: 1235-1244.
83. Mestdagh P, Bostrom AK, Impens F, Fredlund E, Van Peer G, et al. (2010) The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol Cell 40: 762-773.
84. Oeztuerk-Winder F, Guinot A, Ochalek A, Ventura JJ, (2012) Regulation of human lung alveolar multipotent cells by a novel p38alpha MAPK/miR-17-92 axis. EMBO J 31: 3431-3441.
85. Petrocca F, Vecchione A, Croce CM, (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194.
86. Wang S, Olson EN, (2009) AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 19: 205-211.
87. Philippe L, Alsaleh G, Pichot A, Ostermann E, Zuber G, et al. (2013) MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes. Ann Rheum Dis 72: 1071-1079.
88. Yin R, Bao W, Xing Y, Xi T, Gou S, (2012) MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells. Biochem Biophys Res Commun 417: 771-776.
89. Yin R, Wang R, Guo L, Zhang W, Lu Y, (2012) MiR-17-3p Inhibits Angiogenesis by Downregulating Flk-1 in the Cell Growth Signal Pathway. J Vasc Res 50: 157-166.
90. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, et al. (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 104: 1184-1191.
91. Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, et al. (2013) Tumor necrosis factor alpha-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-kappaB signaling. Arthritis Rheum 65: 916-927.
92. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, et al. (2004) The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64: 2774-2781.
93. Keller S, Konig AK, Marme F, Runz S, Wolterink S, et al. (2009) Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 278: 73-81.
94. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, et al. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305.
95. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807.
96. Gourzones C, Gelin A, Bombik I, Klibi J, Verillaud B, et al. (2010) Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 7: 271.
97. Dittmer DP, (2011) Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy. MBio 2: e00138-00111.
98. Roy D, Sin SH, Lucas AS, Venkataramanan R, Wang L, et al. (2013) mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis. Cancer Res 73: 2235-2246.
99. Bechtel J, Grundhoff A, Ganem D, (2005) RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79: 10138-10146.
100. Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R, (2012) RNAs in Epstein-Barr virions control early steps of infection. Proc Natl Acad Sci U S A 109: E1396-1404.
101. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C, (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17: 879-887.
102. Chen W, Sin SH, Wen KW, Damania B, Dittmer DP, (2012) Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS Pathog 8: e1003048.
103. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
104. Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, et al. (2007) Exosomes with immune modulatory features are present in human breast milk. J Immunol 179: 1969-1978.
105. Punj V, Matta H, Schamus S, Tamewitz A, Anyang B, et al. (2010) Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 29: 1835-1844.
106. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
107. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, et al. (2012) MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res.
108. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
109. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, et al. (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 109: E2110-2116.
110. Chaput N, Flament C, Viaud S, Taieb J, Roux S, et al. (2006) Dendritic cell derived-exosomes: biology and clinical implementations. J Leukoc Biol 80: 471-478.
111. Escudier B, Dorval T, Chaput N, Andre F, Caby MP, et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3: 10.
112. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, et al. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4: 594-600.
113. Dai S, Wei D, Wu Z, Zhou X, Wei X, et al. (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16: 782-790.
114. Mi H, Muruganujan A, Thomas PD, (2013) PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 41: D377-386.